# BioFreedom US IDE Feasibility Trial

> **NCT02131142** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Biosensors Europe SA** · enrollment: 72 (actual)

## Conditions studied

- Ischemic Heart Disease
- Stable Angina
- Unstable Angina
- Silent Ischemia

## Interventions

- **DEVICE:** BioFreedom drug coated coronary stent

## Key facts

- **NCT ID:** NCT02131142
- **Lead sponsor:** Biosensors Europe SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-08
- **Primary completion:** 2015-08
- **Final completion:** 2019-07
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2015-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02131142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02131142, "BioFreedom US IDE Feasibility Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02131142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*